Skip to content
Popular Searches
  • # Cancer
  • # FDA
  • # Hoffmann-La Roche
  • # Alzheimer's
  • # DNA
  • # Diabetes
  • linkedin
  • facebook
  • instagram
  • twitter
  • youtube
Home BiotechReality – Covering Industry, Business, and Academia

Explore the frontiers of Biotechnology, Pharma/Biopharma industry and Science with BiotechReality. We publish news, reports, views and articles.

  • Healthcare & Pharmaceuticals
    • Business
    • Pharmacology
  • Clinical Trials
    • Regulatory Approval
  • Biotechnology
    • Molecular Biology
    • Genomics
    • Immunology
    • Microbiology
      • Virology
    • Diagnostic Tests
  • Science
    • Microbiology
    • Research
    • General Biology
  • Technology
    • Artificial Intelligence
  • News
    • Research
Trending

Trending

Scientists Use Artificial Neurons to “Imitate Real Biological Processes”

30 January 2025

How the molecular dynamics of CAR T cells influence their ability to cancer-killing behavior

13 January 2025

Our Brain Cells Are Being Flinged by Mitochondria with Their DNA

23 August 2024

Novo Nordisk’s CagriSema for Obesity and Type 2 Diabetes Shows Superior Results in REDEFINE 2 Trial

10 March 2025

Roche’s Supplemental Biologics License Application of Gazyva/Gazyvaro (Obinutuzumab) for The Treatment of Lupus Nephritis Accepted by U.S. FDA

6 March 2025

Dire Wolf Returns After 12000 Years By De-Extinction Technology

9 April 2025

Menstrual Cycle – Action of Ovarian Hormones and Folliculogenesis

15 August 2023

Aldeyra Therapeutics Responds to the U.S. FDA’s Denial of Reproxalap’s NDA Application for Treating Signs and Symptoms of Dry Eye Disease

3 April 2025

Roche Announces Positive Long-Term Study Results of Perjeta-based (pertuzumab) Regimen for Breast Cancer Treatment

13 May 2025

Researchers Reveal Alarming Variations in a Key Cancer Immunotherapy Target Between Humans and Mice

7 January 2025

Chi-square Test – Formula and Applications

4 February 2024

Blocking the DNA triplication by a newly discovered protein

5 March 2024

Medical Devices

Johnson & Johnson MedTech Reports Strong Clinical Outcomes for MONARCH™ Robotic Bronchoscopy in Largest Study to Date
Clinical Trials Medical Devices News

Johnson & Johnson MedTech Reports Strong Clinical Outcomes for MONARCH™ Robotic Bronchoscopy in Largest Study to Date

Athulya B S 29 May 2025

Johnson & Johnson MedTech’s MONARCH™ Platform demonstrated 98.7% navigation success and 83.2% diagnostic yield in the TARGET study, confirming its safety and efficacy for robotically assisted bronchoscopy.

Abbott’s Tendyne™ Device Receives FDA Approval for Minimally Invasive Mitral Valve Replacement
Healthcare & Pharmaceuticals Medical Devices News Regulatory Approval

Abbott’s Tendyne™ Device Receives FDA Approval for Minimally Invasive Mitral Valve Replacement

Athulya B S 28 May 2025

Abbott’s Tendyne™ device has secured FDA approval, revolutionizing mitral valve replacement. This minimally invasive system offers a crucial alternative for high-risk patients with severe mitral annular calcification, eliminating the need for open-heart surgery.

Abbott’s FreeStyle Libre® Technology Linked to Significant Reduction in Heart-Related Hospitalizations for Diabetes Patients
Clinical Trials Diabetes Medical Devices News

Abbott’s FreeStyle Libre® Technology Linked to Significant Reduction in Heart-Related Hospitalizations for Diabetes Patients

Ajmal Aseem 16 May 2025

In addition, the research showed an 80% reduction in the hospitalization risk of cardiovascular disease in individuals with Type 1 diabetes who did not have a previous history of such illnesses.

Johnson & Johnson Launches MENTOR™ MemoryGel™ Breast Implants for Reconstruction Patients
Cancer Healthcare & Pharmaceuticals Medical Devices News

Johnson & Johnson Launches MENTOR™ MemoryGel™ Breast Implants for Reconstruction Patients

Athulya B S 14 May 2025

The creation of these implants is a direct answer to the demands of patients who need primary or revision reconstruction following a mastectomy.

Roche granted FDA breakthrough device designation for VENTANA TROP2, an AI-driven companion diagnostic for non-small cell lung cancer
Business Medical Devices News Regulatory

Roche granted FDA breakthrough device designation for VENTANA TROP2, an AI-driven companion diagnostic for non-small cell lung cancer

Athulya B S 29 April 2025

The gadget analyzes images using artificial intelligence to achieve a degree of diagnosis accuracy that is not achievable with conventional manual grading techniques.

Areas Covered

  • Anti-obesity Drugs
  • Artificial Intelligence
  • Astrobiology
  • Biochemistry
  • Bioengineering
  • Bioinformatics
  • Biostatistics
  • Biotechnology
  • Blog
  • Business
  • Cancer
  • Cell Biology
  • Clinical Investigation
  • Clinical Trials
  • Collection
  • Deep Learning
  • Diabetes
  • Diagnostic Tests
  • Disease Biology
  • Diseases
  • Drug Discovery
  • Drugs
  • Engineering
  • Epidemiology
  • Gene Therapy
  • General Biology
  • Genetics
  • Genomics
  • Healthcare & Pharmaceuticals
  • Immunology
  • Immunotherapy
  • Instrumentation
  • Laboratory Info
  • Life Sciences
  • Machine Learning
  • Medical Devices
  • Mental Health
  • Microbiology
  • Microscopy
  • Molecular Biology
  • Nanotechnology
  • Neuroscience
  • News
  • Oncology
  • Pharmacology
  • Regenerative Medicine
  • Regulatory
  • Regulatory Approval
  • Research
  • Science
  • Science Communication
  • Supply Chain
  • Technology
  • Therapies
  • Toxicology
  • Vaccines
  • Virology
  • Weight-loss Drugs
Market Analysis
Publish on BiotechReality

  • PhD Position in Food Biotechnology – University of Reading, United Kingdom
  • Novo Nordisk Engineering (NNE) is Hiring a Manufacturing Execution System (MES) Analyst in Bengaluru, India
  • Sartorius is Hiring a Process Technology Engineer in Bengaluru, India – May, 2025
  • Cytiva Hiring a Logistics Specialist in Singapore – May 2025
  • AstraZeneca is Hiring an AI Engineer – Lead Consultant in Chennai, India – May 2025
SciRealityPress BiotechReality

A SciRealityPress Associate

Contents in the website is licensed under CC BY-NC 4.0

Disclaimer: The content on this website is not meant to provide medical or any other professional advice. Understand and use the information, double check if necessary. All trademarked names mentioned in the contents belongs to their respective owners. Stock exchange data providing by Stockdio

SciRealityPress © 2025
  • About
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
  • Platform Status
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinuePrivacy policy